Results 21 to 30 of about 874,057 (168)

Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma

open access: yesActa Dermato-Venereologica, 2019
Methotrexate has demonstrated its efficiency for the treatment of juvenile localized scleroderma but some patients may be resistant. The aim of our study was to define the profile of such patients.
Juliette Hardy   +19 more
doaj   +2 more sources

Sarcopenia in juvenile localized scleroderma: new insights on deep involvement

open access: yesEuropean Radiology, 2020
Juvenile localized scleroderma (JLS) is a rare chronic autoimmune disease which can also affect bones and muscles. Nevertheless, muscle loss was not previously investigated in patients with JLS. Thus, the aim of this study was to retrospectively evaluate deep involvement and assess and quantify sarcopenia in JLS patients using magnetic resonance ...
Silvia Karem Janet Flores Quispe   +7 more
openaire   +3 more sources

A Rare Case of Juvenile Systemic Sclerosis: Clinical Challenges and Management

open access: yesAnnals of Rheumatology and Autoimmunity
Scleroderma is “skleros” sclerosing or hardening of the “derma” skin. It includes both systemic and localized scleroderma (LS). Mostly, juvenile LS affects the skin, whereas juvenile systemic sclerosis (SSc) involves multiple organ systems.
Areej Bano   +2 more
doaj   +2 more sources

Esophageal involvement in juvenile localized scleroderma: a pilot study.

open access: yesClinical and experimental rheumatology, 2007
To evaluate the esophageal involvement in patients with juvenile localized scleroderma (JLS).A cohort of patients with JLS underwent esophageal stationary manometry to evaluate esophageal motility and lower esophageal sphincter (LES) function, distal esophagus 24-hour pH-monitoring to detect gastroesophageal reflux (GER) and upper gastrointestinal (GI)
Guariso G.   +5 more
openaire   +4 more sources

Long-term methotrexate efficacy in juvenile localized scleroderma [PDF]

open access: yesPediatric Rheumatology Online Journal, 2011
Giuliotto S   +5 more
doaj   +2 more sources

Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS) [PDF]

open access: yesPediatric Rheumatology Online Journal, 2012
Li Suzanne C   +13 more
doaj   +2 more sources

Calcinosis Cutis and Delayed-Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge. [PDF]

open access: yesPediatr Dermatol
ABSTRACT A 16‐year‐old girl presenting with calcinosis cutis and localized scleroderma subsequently developed delayed‐onset idiopathic inflammatory myopathy five years after initial skin involvement. Despite the absence of typical dermatomyositis features and negative myositis‐specific antibodies, whole‐body MRI revealed extensive subclinical muscle ...
Marrani E   +5 more
europepmc   +2 more sources

Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. [PDF]

open access: yesArthritis Care Res (Hoboken), 2012
AbstractObjectiveJuvenile localized scleroderma (LS) is a chronic inflammatory skin disorder associated with substantial morbidity and disability. Although a wide range of therapeutic strategies has been reported in the literature, a lack of agreement on treatment specifics and accepted methods for clinical assessment has made it difficult to compare ...
Li SC   +24 more
europepmc   +4 more sources

Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity. [PDF]

open access: yesClin Transl Med
Nailfold capillaroscopy is a non‐invasive imaging tool that can aid in the diagnosis and monitoring of juvenile myositis. Branched nailfold capillary morphology is more common in juvenile myositis patients, particularly those positive for TIF1γ+ autoantibodies. Juvenile myositis patients with more active disease demonstrate increased microhaemorrhages,
McClellan N   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy